Validair Monitoring Solutions has secured new funding that will be used to support the growth of the company across the UK.
United Kingdom-based company, Validair Monitoring Solutions has secured new funding that will be used to support the growth of the company across the UK, it announced in a recent press release.
“Validair is already highly regarded in its core markets across the pharmaceutical and life sciences sector,” explained Validair managing director, Steve Wake. “Now we are driving Validair’s expansion into sectors that increasingly recognize the positive impact of cleanrooms and precision contamination control in research, production, and product testing facilities.”
The £150,000 (approximately $197,000) investment was provided by the Midlands Engine Investment Fund. Through the investment, Validair will grow its number of employees to support new market applications.
“In regulated industries such as biotech, medical devices, food production, and pharma, environmental monitoring and compliance are mandated. Some newer applications less so,” added Wake. “But we see manufacturers in commercial marketplaces looking to drive-up their process quality to add value and a competitive advantage to their products. As a turnkey solutions provider, we are in the ideal position to help them deliver that value.”
Source: Validair Monitoring Solutions
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.